Tofacitinib Solution
NDC 70095-008
Product Information
Tofacitinib is a ANDA-approved product labeled by Sun Pharmaceutical Industries, Inc.. This medication is typically used as a janus kinase inhibitor [epc]. It is supplied as a solution for oral administration. This product entry covers the primary NDC 70095-008 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 70095-008?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOFACITINIB CITRATE (UNII: O1FF4DIV0D)
- TOFACITINIB (UNII: 87LA6FU830) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- LACTIC ACID, UNSPECIFIED FORM (UNII: 33X04XA5AT)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- XYLITOL (UNII: VCQ006KQ1E)
- GRAPE (UNII: 6X543N684K)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2478433 - tofacitinib 1 MG/mL Oral Solution
- RxCUI: 2478433 - tofacitinib 1 MG/ML Oral Solution
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.